DOES MINIMALLY-INVASIVE BYPASS SURGERY AFFORD A LONG-TERM SURVIVAL ADVANTAGE COMPARED WITH DRUG-ELUTING STENT FOR ISOLATED COMPLEX DISEASE OF THE LEFT ANTERIOR DESCENDING CORONARY ARTERY?

No significant difference in long-term survival has, as yet, been identified for patients with isolated proximal lesions of the left anterior descending (LAD) coronary artery undergoing either robotic-assisted minimally-invasive coronary artery bypass (MIDCAB) or percutaneous intervention (PCI) with